![]() |
市场调查报告书
商品编码
1451371
2024-2032 年按技术、应用(慢性阻塞性肺病、气喘、呼吸窘迫症候群、睡眠呼吸中止症等)、最终用户和地区分類的便携式製氧机市场报告Portable Oxygen Concentrators Market Report by Technology, Application (Chronic Obstructive Pulmonary Disease, Asthma, Respiratory Distress Syndrome, Sleep Apnea, and Others), End User, and Region 2024-2032 |
2023年,全球便携式製氧机市场规模达到18亿美元。展望未来, IMARC Group预计到2032年市场规模将达到34亿美元,2024-2032年复合年增长率(CAGR)为7.3%。慢性阻塞性肺病、气喘和囊性纤维化等呼吸系统疾病发病率的上升、对家庭医疗护理的日益偏好以及老年人口的增加是推动市场的一些主要因素。
携带式製氧机 (POC) 是为患有呼吸系统疾病的人提供集中氧气供应的医疗设备。它们旨在随时随地提供氧气治疗,使患者能够保持积极的生活方式,并在传统医疗环境之外获得必要的氧气支持。与依赖氧气瓶或固定式浓缩器的传统氧疗方法不同,这些浓缩器结构紧凑、重量轻且易于运输。它们的工作原理是吸入周围空气,过滤掉氮气和其他气体,并向使用者提供更高浓度的氧气。
该市场主要是由二氧化碳(CO2)排放造成的环境污染不断增加所推动的。此外,在氧气水平不足的地方,旅行者和登山者对 POC 的需求不断增加,这是另一个主要的成长诱导因素。此外,技术进步对市场的成长做出了巨大贡献。製造商不断创新,开发轻巧、紧凑和用户友好的设备,为患者提供增强的便携性和便利性,这也促进了市场的成长。此外,全球医疗保健基础设施支出的不断增长也推动了市场的成长。此外,由于移动方便,患有睡眠呼吸中止症的患者对便携式製氧机的需求不断增长,这在全球范围内创造了良好的市场前景。
呼吸道疾病发生率上升
越来越多的人被诊断出患有肺癌、慢性阻塞性肺病、气喘、肺纤维化和流感等呼吸系统疾病,因此需要有效的氧气治疗解决方案。 POC 提供了一种便携式且方便的选择,用于向患者输送氧气,使他们能够管理自己的病情并提高生活品质。呼吸系统疾病发生率的上升直接导致市场对POC的需求增加。此外,POC 使医疗保健提供者能够将护理扩展到医院之外,促进家庭氧气治疗并减轻医疗机构的负担。此外,与传统氧气治疗方法相比,POC 是一种经济高效的解决方案,因为它们无需频繁补充钢瓶或固定浓缩器维护。
人们越来越偏好家庭医疗服务
家庭医疗强调需要便携式医疗设备,使患者无需局限于医院或诊所即可接受治疗。 POC 提供了一种方便、轻巧的解决方案,用于在家中进行氧气治疗,从而满足了这项要求。因此,人们对居家照护的日益青睐导致对便携式製氧机的需求不断增加。此外,居家医疗保健可以减少住院时间、再入院和急诊就诊次数,从而为医疗保健系统提供潜在的成本节约。 POC 使患者能够在家中接受氧气治疗,从而最大限度地减少因呼吸系统疾病而住院的需要。医疗保健资源和成本效益的优化是将 POC 整合到家庭护理策略中的驱动因素。
老年人口不断增加
随着个体年龄的增长,慢性阻塞性肺病 (COPD)、肺炎和其他肺部相关疾病等呼吸系统疾病的风险也会增加。这些情况通常需要长期氧气治疗来控制症状并改善生活品质。因此,老年人口的增加直接导致呼吸系统疾病盛行率的增加,从而导致对作为氧气治疗基本医疗设备的 POC 的需求增加。此外,POC 为老年人提供必要的移动性和便携性,使其能够继续积极的生活方式,同时获得所需的氧气支持。老年人口对积极老化的渴望推动了对 POC 的需求,使他们能够充分参与他们想要的活动。
The global portable oxygen concentrators market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.4 Billion by 2032, exhibiting a growth rate (CAGR) of 7.3% during 2024-2032. The rising incidences of respiratory diseases such as chronic obstructive pulmonary disease, asthma, and cystic fibrosis, the growing preference for home-based medical care, and the increasing geriatric population are some of the major factors propelling the market.
Portable oxygen concentrators (POCs) are medical devices that provide a concentrated supply of oxygen to individuals with respiratory conditions. They are designed to deliver oxygen therapy on-the-go, allowing patients to maintain an active lifestyle and receive the necessary oxygen support outside of traditional healthcare settings. These concentrators are compact, lightweight, and easily transportable unlike traditional oxygen therapy methods that rely on oxygen cylinders or stationary concentrators. They operate by drawing in ambient air, filtering out nitrogen and other gases, and delivering a higher concentration of oxygen to the user.
The market is primarily driven by the increasing amount of environmental pollution due to carbon dioxide (CO2) emissions. In addition, the escalating demand for POCs by travelers and mountaineers in places wherein the oxygen level is inadequate represents another major growth-inducing factor. Besides, technological advancements have significantly contributed to the growth of the market. Manufacturers are continuously innovating to develop lightweight, compact, and user-friendly devices that offer enhanced portability and convenience for patients, which is also augmenting the market growth. Moreover, the growing expenditure on healthcare infrastructure across the globe is also propelling the market growth. Furthermore, the rising demand for portable oxygen concentrators for the patients suffering from sleep apnea due to its easy of mobility, is creating a favorable market outlook across the globe.
The rising incidences of respiratory diseases
The growing number of individuals diagnosed with respiratory diseases such as lung cancer, COPD, asthma, pulmonary fibrosis, and flu, necessitates the availability of effective oxygen therapy solutions. POCs offer a portable and convenient option for delivering oxygen to patients, enabling them to manage their conditions and improve their quality of life. The rising incidences of respiratory diseases are directly contributing to the increased demand for POCs in the market. Moreover, POCs enable healthcare providers to extend care beyond the hospital walls, facilitating home-based oxygen therapy and reducing the burden on healthcare facilities. Additionally, POCs can be a cost-effective solution compared to traditional oxygen therapy methods, as they eliminate the need for frequent cylinder refills or stationary concentrator maintenance.
The growing preference for home-based medical care
Home-based medical care emphasizes the need for portable medical devices that enable patients to receive treatment without being confined to a hospital or clinic. POCs align with this requirement by providing a convenient and lightweight solution for delivering oxygen therapy at home. As a result, the growing preference for home-based care is escalating the demand for portable oxygen concentrators. Moreover, home-based medical care offers potential cost savings for healthcare systems by reducing hospital stays, readmissions, and emergency department visits. POCs enable patients to receive oxygen therapy at home, minimizing the need for hospital admissions related to respiratory conditions. This optimization of healthcare resources and cost-effectiveness is a driving factor in the integration of POCs into home-based care strategies.
The increasing geriatric population
As individuals age, the risk of developing respiratory conditions such as chronic obstructive pulmonary disease (COPD), pneumonia, and other lung-related ailments increases. These conditions often require long-term oxygen therapy to manage symptoms and improve the quality of life. Consequently, the rising geriatric population directly contributes to the increased prevalence of respiratory diseases, leading to a higher demand for POCs as an essential medical device for oxygen therapy. Moreover, POCs offer the necessary mobility and portability for the elderly population to continue their active lifestyle while receiving the oxygen support they require. The desire for active aging among the geriatric population drives the demand for POCs that enable them to participate fully in their desired activities.
IMARC Group provides an analysis of the key trends in each segment of the global portable oxygen concentrators market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on technology, application, and end user.
Continuous Flow
Pulse Flow
Pulse flow presently dominates the market
The report has provided a detailed breakup and analysis of the market based on technology. This includes continuous flow and pulse flow. According to the report, pulse flow represented the largest segment.
Pulse flow POCs operate by delivering oxygen in a pulsed or intermittent fashion, synchronized with the patient's inhalation. This intermittent delivery method allows for significant battery savings compared to continuous flow POCs. By delivering oxygen only when the patient breathes in, pulse flow POCs conserve energy, resulting in extended battery life. This feature is highly valued by users as it provides them with greater mobility and independence, allowing them to use the POC for longer durations without the need for frequent recharging or battery replacements. Moreover, these POCs are typically smaller, lighter, and more compact compared to continuous flow devices. This compact design enhances portability and ease of use, enabling users to carry the POC with them wherever they go. The lightweight nature and smaller size of pulse flow POCs contribute to their popularity among individuals who require oxygen therapy while maintaining an active lifestyle or traveling.
Chronic Obstructive Pulmonary Disease (COPD)
Asthma
Respiratory Distress Syndrome
Sleep Apnea
Others
Chronic obstructive pulmonary disease (COPD) represents the leading segment
A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes chronic obstructive pulmonary disease (COPD), asthma, respiratory distress syndrome, sleep apnea, and others. According to the report, chronic obstructive pulmonary disease (COPD) represented the largest segment.
COPD is a prevalent respiratory disease globally, with a significant number of individuals diagnosed with the condition. The high prevalence of COPD directly translates to a larger patient base in need of oxygen therapy, driving the demand for POCs. Oxygen therapy plays a crucial role in managing COPD and improving patients' quality of life as many individuals with COPD require long-term oxygen therapy to maintain adequate oxygen levels and alleviate symptoms such as shortness of breath. Besides, the POC market has witnessed significant technological advancements, improving the performance, efficiency, and convenience of POCs for COPD patients. Advanced sensors, algorithms, and control systems in POCs enable precise oxygen delivery, synchronization with the patient's breath, and extended battery life. These technological advancements enhance the user experience, making POCs more user-friendly and reliable for COPD patients.
Hospitals
Ambulatory Surgery Centers
Others
Ambulatory surgery centers hold the largest share in the market
A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, ambulatory surgery centers, and others. According to the report, ambulatory surgery centers represented the largest segment.
ASCs have witnessed significant growth and popularity in recent years due to various advantages they offer. ASCs provide a cost-effective alternative to inpatient hospital stays, allowing patients to undergo surgical procedures in a more efficient and comfortable setting. The increasing number of ASCs globally directly contributes to the larger customer base and demand for POCs in these facilities. Moreover, many surgical procedures performed in ASCs require the administration of supplemental oxygen to ensure patient safety and comfort. POCs are the preferred choice for oxygen therapy in ASCs due to their portability, ease of use, and convenience. The compact size and mobility of POCs make them well-suited for use in outpatient settings, enabling patients to receive oxygen therapy while moving around the facility.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest portable oxygen concentrators market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market.
North America has a significant prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, and other lung-related ailments. The region's aging population, environmental factors, and lifestyle choices contribute to the higher occurrence of respiratory conditions. The greater prevalence of these diseases creates a larger patient base in need of oxygen therapy, driving the demand for POCs in North America. Moreover, the region boasts a well-developed healthcare infrastructure, characterized by advanced medical facilities, a robust healthcare system, and significant investments in healthcare research and development. The presence of advanced hospitals, clinics, and ambulatory surgery centers creates a conducive environment for the adoption of POCs. Besides, the POC market has witnessed continuous technological advancements, and North America has been at the forefront of these innovations. The region is home to several key players in the healthcare and medical device industry, fostering a culture of research and development.
The competitive landscape of the market is characterized by the presence of several key players competing to gain market share. These companies strive to develop innovative products, expand their distribution networks, and provide comprehensive after-sales support. Nowadays, the leading players are investing in research and development (R&D) activities to develop advanced product variants. They are also designing a diverse range of POC models designed for both home and travel use. Moreover, various key players are engaging in collaborations and mergers and acquisitions (M&As) to strengthen their market foothold and gain a competitive edge in the market.
Caire Inc. (NGK Spark Plug Co. Ltd)
Chart Industries Inc.
Drive Devilbiss Healthcare Limited (Drive International LLC)
Inogen Inc.
Invacare Corporation
Koninklijke Philips N.V
Nidek Medical India Pvt Ltd
O2 Concepts LLC
Precision Medical Inc. (BioHorizons Inc.)
Resmed Inc.
Teijin Limited
Philips Respironics, a subsidiary of Philips company, is introducing a range of POCs with advanced features such as extended battery life, user-friendly interfaces, and connectivity options.
Inogen Inc., a leading manufacturer of POCs specializing in lightweight and portable devices, is focusing on direct-to-consumer sales and providing excellent customer service to strengthen its market foothold.
ResMed Inc., a leading provider of medical devices and solutions for sleep apnea and respiratory disorders, has expanded its portfolio to include POCs that offer advanced features, comfort, and efficient oxygen delivery. The company is also integrating technology and data connectivity to enhance patient monitoring and therapy management.